Rigel Pharmaceuticals Inc. (New) (RIGL) is a publicly traded Healthcare sector company. As of May 21, 2026, RIGL trades at $28.82 with a market cap of $529.34M and a P/E ratio of 1.41. RIGL moved +2.08% today. Year to date, RIGL is -30.03%; over the trailing twelve months it is +43.24%. Its 52-week range spans $13.57 to $52.24. Analyst consensus is buy with an average price target of $54.00. Rallies surfaces RIGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rigel Pharmaceuticals Inc. (New) (RIGL) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. RIGL moved +2.08% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $28.82 |
| Market Cap | $529.34M |
| P/E Ratio | 1.41 |
| EPS | $20.23 |
| Dividend Yield | 0.00% |
| 52-Week High | $52.24 |
| 52-Week Low | $13.57 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $299.77M |
| Net Income | $364.23M |
| Gross Margin | 93.39% |
4 analysts cover RIGL: 0 strong buy, 2 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $54.00.